← 返回专利悬崖列表






枸橼酸托法替布
Tier B · 提前布局Tofacitinib Citrate · 2028 年到期全部品种 →
辉瑞
原研
2012
首批上市
2028
到期年(公开口径)
$2.46B ▲
峰值销售
化学药
类型
靶点:JAK1、JAK2、JAK3
商品名:Xeljanz、尚杰、安舒正、Jakvinus
适应症(已批准):强直性脊柱炎、幼年型类风湿性关节炎、溃疡性结肠炎、银屑病关节炎、类风湿关节炎
各地区研发/上市状态
美国
批准上市
2012-11-06
欧盟
批准上市
2017-03-21
中国
批准上市
2017-03-10
日本
批准上市
2013-03-25
合成路线与中间体7 routes
原研路线 × 1优化路线(非专利)× 5工艺路线 × 1
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 4 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-001 | 32018-96-5在售 | 1-benzyl-4-methylpiperidin-3-one |
| TOFA-002 | 384338-23-2在售 | 1-benzyl-N,4-dimethylpiperidin-3-amine |
| TOFA-003 | 3680-69-1在售 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-004 | 384337-90-0在售 | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-005 | 384336-73-6在售 | N-methyl-N-(4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-006 | 16130-58-8在售 | 2-cyanoacetyl chloride |
优化Route 3步骤 7 · 总收率 42.85 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-013 | 477600-71-8在售 | (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine hemi((2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate) |
| TOFA-014 | 90213-66-4在售 | 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-015 | 923036-25-3在售 | N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-002 | 384338-23-2在售 | 1-benzyl-N,4-dimethylpiperidin-3-amine |
| TOFA-005 | 384336-73-6在售 | N-methyl-N-(4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-009 | 105-56-6在售 | ethyl 2-cyanoacetate |
| TOFA-010 | 694495-63-1在售 | methyl (4-methylpyridin-3-yl)carbamate |
| TOFA-011 | 923036-29-7在售 | 1-benzyl-3-((methoxycarbonyl)amino)-4-methylpyridin-1-ium chloride |
| TOFA-012 | 923036-28-6在售 | methyl (1-benzyl-4-methyl-1,2,5,6-tetrahydropyridin-3-yl)carbamate |
优化Route 4步骤 5 · 总收率 1.1 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-002 | 384338-23-2在售 | 1-benzyl-N,4-dimethylpiperidin-3-amine |
| TOFA-003 | 3680-69-1在售 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-004 | 384337-90-0在售 | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-005 | 384336-73-6在售 | N-methyl-N-(4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-013 | 477600-71-8在售 | (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine hemi((2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate) |
| TOFA-016 | 1228879-37-5在售 | 1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
| TOFA-017 | 56657-76-2在售 | 2,5-dioxopyrrolidin-1-yl 2-cyanoacetate |
优化Route 5步骤 12 · 总收率 25 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-010 | 694495-63-1在售 | methyl (4-methylpyridin-3-yl)carbamate |
| TOFA-018 | 3430-27-1在售 | 4-methylpyridin-3-amine |
| TOFA-019 | 1204176-45-3在售 | methyl (4-methylpiperidin-3-yl)carbamate |
| TOFA-020 | 1616760-91-8在售 | methyl (4-methyl-1-tritylpiperidin-3-yl)carbamate |
| TOFA-021 | - | N,4-dimethyl-1-tritylpiperidin-3-amine hydrochloride |
| TOFA-022 | 1616761-04-6在售 | (3R,4R)-N,4-dimethyl-1-tritylpiperidin-3-amine (2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate |
| TOFA-023 | 1616760-93-0在售 | (3R,4R)-N,4-dimethyl-1-tritylpiperidin-3-amine |
| TOFA-024 | 934524-10-4在售 | 2,4-dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-025 | 1616760-94-1在售 | 2-chloro-N-methyl-N-((3R,4R)-4-methyl-1-tritylpiperidin-3-yl)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-026 | 1616760-96-3在售 | 2-chloro-N-methyl-N-((3R,4R)-4-methyl-1-tritylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-027 | 1616760-97-4在售 | 2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-028 | 372-09-8在售 | 2-cyanoacetic acid |
优化Route 6步骤 5 · 总收率 23.6 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-004 | 384337-90-0在售 | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-005 | 384336-73-6在售 | N-methyl-N-(4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-006 | 16130-58-8在售 | 2-cyanoacetyl chloride |
| TOFA-029 | 108-89-4在售 | 4-methylpyridine |
| TOFA-030 | 32018-56-7在售 | 1-benzyl-4-methyl-1,2,3,6-tetrahydropyridine |
| TOFA-031 | 58878-98-1在售 | (3S,4R)-1-benzyl-4-methylpiperidin-3-ol |
| TOFA-032 | 78727-16-9在售 | N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
优化Route 7步骤 4 · 总收率 63.4 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-003 | 3680-69-1在售 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-028 | 372-09-8在售 | 2-cyanoacetic acid |
| TOFA-033 | 1206824-89-6在售 | tert-butyl methyl((3R,4R)-4-methylpiperidin-3-yl)carbamate |
| TOFA-034 | 1629858-77-0在售 | tert-butyl ((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)carbamate |
| TOFA-035 | 1629858-78-1在售 | 3-((3R,4R)-4-methyl-3-(methylamino)piperidin-1-yl)-3-oxopropanenitrile |
工艺Route 2步骤 5 · 总收率 2.08 kg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| TOFA-002 | 384338-23-2在售 | 1-benzyl-N,4-dimethylpiperidin-3-amine |
| TOFA-003 | 3680-69-1在售 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-004 | 384337-90-0在售 | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-005 | 384336-73-6在售 | N-methyl-N-(4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-007 | 1639406-86-2在售 | 4-chloro-7-(methylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine |
| TOFA-008 | 1639406-87-3在售 | N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-(methylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| TOFA-009 | 105-56-6在售 | ethyl 2-cyanoacetate |
常见问题(FAQ)
枸橼酸托法替布的适应症有哪些?
已批准的适应症包括:强直性脊柱炎、幼年型类风湿性关节炎、溃疡性结肠炎、银屑病关节炎、类风湿关节炎。
枸橼酸托法替布的专利什么时候到期?
按公开口径,枸橼酸托法替布的专利到期年为 2028 年。
枸橼酸托法替布有几条合成路线?
本站收录 7 条合成路线,最短路线 4 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。
枸橼酸托法替布的关键中间体在哪里可以采购?
枸橼酸托法替布的多条路线中间体已挂接 CAS 档案,其中 34 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取枸橼酸托法替布中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24